An Update on Tobacco Control Initiatives in Comprehensive Cancer Control Plans

Dunne, Katherine; Henderson, Sheryl L.; Stewart, Sherri L.; Moore, Angela; Hayes, Nikki; Jordan, Jerelyn; Underwood, J. Michael

doi:10.5888/pcd10.120331

Cited by 5 publications

(7 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For example, two-thirds of NCCCP programs include funding for tobacco control, such as supporting cessation services and smoke-free policies. 46 NCCCP programs work with a national network of partner organizations to reach populations that tend to be heavy smokers. 47 Continued and expanded access to tobacco-cessation services could increase abstinence rates and decrease lung cancer incidence further.…”

Section: Discussionmentioning

confidence: 99%

Lung cancer survival in the United States by race and stage (2001‐2009): Findings from the CONCORD‐2 study

Richards

Henley

Puckett

et al. 2017

Cancer

View full text Add to dashboard Cite

BACKGROUND Results from the second CONCORD study (CONCORD-2) indicated that 5-year net survival for lung cancer was low (range, 10%–20%) between 1995 and 2009 in most countries, including the United States, which was at the higher end of this range. METHODS Data from CONCORD-2 were used to analyze net survival among patients with lung cancer (aged 15–99 years) who were diagnosed in 37 states covering 80% of the US population. Survival was corrected for background mortality using state-specific and race-specific life tables and age-standardized using International Cancer Survival Standard weights. Net survival was estimated for patients diagnosed between 2001 and 2003 and between 2004 and 2009 at 1, 3, and 5 years after diagnosis by race (all races, black, and white); Surveillance, Epidemiology, and End Results Summary Stage 2000; and US state. RESULTS Five-year net survival increased from 16.4% (95% confidence interval, 16.3%–16.5%) for patients diagnosed 2001–2003 to 19.0% (18.8%–19.1%) for those diagnosed 2004–2009, with increases in most states and among both blacks and whites. Between 2004 and 2009, 5-year survival was lower among blacks (14.9%) than among whites (19.4%) and ranged by state from 14.5% to 25.2%. CONCLUSIONS Lung cancer survival improved slightly between the periods 2001–2003 and 2004–2009 but was still low, with variation between states, and persistently lower survival among blacks than whites. Efforts to control well established risk factors would be expected to have the greatest impact on reducing the burden of lung cancer, and efforts to ensure that all patients receive timely and appropriate treatment should reduce the differences in survival by race and state.

show abstract

Section: Discussionmentioning

confidence: 99%

Lung cancer survival in the United States by race and stage (2001‐2009): Findings from the CONCORD‐2 study

Richards

Henley

Puckett

et al. 2017

Cancer

View full text Add to dashboard Cite

show abstract

“…Building coalitions around a health or social issue has long been a tactic for community organization (Rodgers et al, 2014). For addressing health disparities, coalitions in multisector partnerships can implement efforts targeting healthrelated behavior change (e.g., dietary intake, physical activity, tobacco cessation, and cancer screening) (Kegler and Swan, 2011;Dunne et al, 2013;Bornstein et al, 2013;Yeary et al, 2011). They can also target a variety of social determinants of health, such as housing, availability of affordable and nutritious foods, resources for physical activity (e.g., sidewalks and bicycle paths), public education, and transportation.…”

Section: Discussionmentioning

confidence: 99%

Participatory Process for Implementing a Colorectal Cancer Screening Intervention: an Action Plan for Local Sustainability

Smith

Ansa

Sheats

et al. 2019

JGPHA

View full text Add to dashboard Cite

Background: Rigid protocols can hamper translation of evidence-based interventions from research to real-world settings. This investigation aimed to develop procedures for modifying the study protocol of a community-based participatory research (CBPR) project and to analyze the theoretical constructs that underlie this process. Methods:The research project is a dissemination and implementation study of the Educational Program to Increase Colorectal Cancer Screening (EPICS), an evidence-based intervention targeting African Americans in the United States. The study is being conducted in a partnership with community coalitions in 15 different cities. Each site initially presented unique issues that required modification of the study protocol. Results:In order to honor underlying CBPR theory, it was necessary to negotiate protocol changes with the community coalition at each site, while insuring preservation of the core elements of the intervention. Conclusions:We discuss the ways in which this represents a narrowing of the gap between CBPR and traditional research approaches.

show abstract

“…Additional support for tobacco prevention and control is available from CDC’s National Comprehensive Cancer Control Program (NCCCP), which in 1998 began providing financial support and technical assistance to states, tribes, and territories to create, implement, and evaluate cancer control plans ( 140 ). A 2013 analysis of 69 NCCCP cancer plans showed that every plan contained at least one CDC-recommended, evidence-based tobacco control strategy ( 141 ). Strategies incorporated were consistent with CDC’s Best Practices for Comprehensive Tobacco Control Programs or The Guide to Community Preventive Services ( 141 ).…”

Section: Discussionmentioning

confidence: 99%

Surveillance for Cancers Associated with Tobacco Use — United States, 2010–2014

Gallaway

Henley

Steele

et al. 2018

MMWR Surveill. Summ.

Self Cite

View full text Add to dashboard Cite

Problem/ConditionTobacco use is the leading preventable cause of cancer, contributing to at least 12 types of cancer, including acute myeloid leukemia (AML) and cancers of the oral cavity and pharynx; esophagus; stomach; colon and rectum; liver; pancreas; larynx; lung, bronchus, and trachea; kidney and renal pelvis; urinary bladder; and cervix. This report provides a comprehensive assessment of recent tobacco-associated cancer incidence for each cancer type by sex, age, race/ethnicity, metropolitan county classification, tumor characteristics, U.S. census region, and state. These data are important for initiation, monitoring, and evaluation of tobacco prevention and control measures.Period Covered2010–2014.Description of SystemCancer incidence data from CDC’s National Program of Cancer Registries and the National Cancer Institute’s Surveillance, Epidemiology, and End Results program were used to calculate average annual age-adjusted incidence rates for 2010–2014 and trends in annual age-adjusted incidence rates for 2010–2014. These cancer incidence data cover approximately 99% of the U.S. population. This report provides age-adjusted cancer incidence rates for each of the 12 cancer types known to be causally associated with tobacco use, including liver and colorectal cancer, which were deemed to be causally associated with tobacco use by the U.S. Surgeon General in 2014. Findings are reported by demographic and geographic characteristics, percentage distributions for tumor characteristics, and trends in cancer incidence by sex.ResultsDuring 2010–2014, approximately 3.3 million new tobacco-associated cancer cases were reported in the United States, approximately 667,000 per year. Age-adjusted incidence rates ranged from 4.2 AML cases per 100,000 persons to 61.3 lung cancer cases per 100,000 persons. By cancer type, incidence rates were higher among men than women (excluding cervical cancer), higher among non-Hispanics than Hispanics (for all cancers except stomach, liver, kidney, and cervical), higher among persons in nonmetropolitan counties than those in metropolitan counties (for all cancers except stomach, liver, pancreatic, and AML), and lower in the West than in other U.S. census regions (all except stomach, liver, bladder, and AML). Compared with other racial/ethnic groups, certain cancer rates were highest among whites (oral cavity and pharyngeal, esophageal, bladder, and AML), blacks (colon and rectal, pancreatic, laryngeal, lung and bronchial, cervical, and kidney), and Asians/Pacific Islanders (stomach and liver). During 2010–2014, the rate of all tobacco-associated cancers combined decreased 1.2% per year, influenced largely by decreases in cancers of the larynx (3.0%), lung (2.2%), colon and rectum (2.1%), and bladder (1.3%).InterpretationAlthough tobacco-associated cancer incidence decreased overall during 2010–2014, the incidence remains high in several states and subgroups, including among men, whites, blacks, non-Hispanics, and persons in nonmetropolitan counties. These disproportionately high rat...

show abstract

An Update on Tobacco Control Initiatives in Comprehensive Cancer Control Plans

Cited by 5 publications

References 12 publications

Lung cancer survival in the United States by race and stage (2001‐2009): Findings from the CONCORD‐2 study

Lung cancer survival in the United States by race and stage (2001‐2009): Findings from the CONCORD‐2 study

Participatory Process for Implementing a Colorectal Cancer Screening Intervention: an Action Plan for Local Sustainability

Surveillance for Cancers Associated with Tobacco Use — United States, 2010–2014

Contact Info

Product

Resources

About